Drug intelligence / Profile preview

Advantra Z

Development stage
Unknown
Lead developer
APT Vet Link
Modality
Small Molecules
Administration
Oral
01

Overview

Advantra Z is a standardized, clinically studied extract of Citrus aurantium (bitter orange), primarily containing the protoalkaloid p-synephrine as its main active component. It is used as a dietary supplement ingredient for weight management, sports nutrition, and energy enhancement. The mechanism of action involves stimulation of beta-3 adrenergic receptors in adipose tissue and muscle, promoting thermogenesis (increased heat production) and lipolysis (breakdown of fat), which can increase resting metabolic rate and support fat loss. Unlike other stimulants such as ephedrine, Advantra Z has minimal impact on cardiovascular parameters like heart rate or blood pressure due to its selectivity for beta-3 over other adrenergic receptors. Multiple clinical studies have demonstrated its safety profile at recommended doses[1][2][4][5][6][7].

Brand names
Advantra Z
Other names
Citrus aurantium extractbitter orange extractp-synephrine (as primary active constituent)
02

Targets

ADRB3 (β3)

Beyond the preview

Go deeper on Advantra Z.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advantra Z.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call